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ABSTRACT
Infective endocarditis (IE) is now rare in
developed countries, but its prevalence is
higher in elderly patients with prosthetic
valves, diabetes, renal impairment, or heart
failure. An increase in health-care associat-
ed IE (HCAIE) has been observed due to
invasive maneuvers (30% of cases).
Methicillin-resistant Staphylococcus aureus
(MRSA) and Enterococcus are the most com-
mon agents in HCAIE, causing high mortal-
ity and morbidity.
We review complications of IE and its thera-
py, based on a patient with acute bivalvular
left-sided MRSA IE and a prosthetic aortic
valve, aggravated by congestive heart fail-
ure, stroke, acute immune complex
glomerulonephritis, Candida parapsilosis
fungémia and death probably due to
Serratia marcescens sepsis. The HCAIE was
assumed to be related to three temporally
associated in-hospital interventions consid-
ered as possible initial etiological mecha-
nisms: overcrowding in the hospital environ-
ment, iv quinolone therapy and red blood
cell transfusion. Later in the clinical course,
Endocardite aguda bi-valvular
esquerda por Estafilococo aureus
meticilino-resistente com complicações
cardíaca, cerebral, renal e sepsis
RESUMO
Em países desenvolvidos a endocardite
infecciosa (EI) é actualmente pouco
frequente, mais prevalente em idosos com
próteses valvulares, diabetes, insuficiência
renal e insuficiência cardíaca. Manobras
invasivas causaram um aumento das
endocardites associadas a cuidados
hospitalares (HCAIE) (30% dos casos),
sendo o Estafilococo aureus meticilino-
resistente e o Enterococo os agentes
infecciosos mais comuns nestes casos,
condicionantes de maiores
mortalidade/morbilidade.
Os autores revêem as complicações da EI e
sua terapêutica, baseados numa doente com
EI aguda bi-valvular esquerda e com
prótese valvular aórtica, complicada de
insuficiência cardíaca, embolia cerebral,
glomerulonefrite aguda pós-infecciosa a
imunocomplexos, funguémia por Candida
612
Rev Port Cardiol 
Vol. 30 Junho 11 / June 11
INTRODUCTION
Staphylococcus aureus (SA) is a majorcause of infective endocarditis (IE) inall age-groups, accounting for around
55% of cases, and is more common in patients
with prosthetic valves or abnormal native
valves(1). SA IE usually presents as a highly
toxic, febrile illness, with frequent focal
metastatic infection and a high rate of heart
failure and central nervous system complica-
tions. New heart murmurs or modification of
previous ones are heard initially in 30-45% of
patients and eventually in 75-85% of cases as
a consequence of progressive valve damage.
Left-sided IE due to SA in non-intravenous
drug abusers has a very high mortality rate in
those aged over 50 years and with significant
underlying diseases and when severe compli-
cations occur, such as major neurological
events, valve dysfunction with heart failure,
and renal failure due to acute glomeru-
lonephritis.  However, in a report from Spain,
Lopez et al. (2) described more frequent valvu-
lar impairment (regurgitation and perforation)
due to left-sided SA endocarditis in younger
patients, the worse prognosis in older patients
being due to comorbidities and higher surgi-
cal mortality.
Patients with IE due to MRSA are signifi-
cantly more likely to present renal failure and
to experience bacteremia than those with IE
due to methicillin-susceptible SA (MSSA).
Risk factors for death due to IE include sever-
ity of illness at onset of bacteremia, MRSA
infection and atrioventricular block. MRSA as
the infecting microorganism in cases of IE is
a risk factor that should be considered for
possible prompt valve resection (3).
Health-care associated IE (HCAIE) is
increasingly being reported in developed
countries, due to increasing age of patients,
comorbidities (diabetes, renal impairment,
previous heart valve disease, and immuno-
suppressive states), and the growing number
of invasive maneuvers with their high risk of
bacteremia (4).
We report a case of an elderly female
patient with previous left-sided bivalvular
fibrocalcifying disease, a prosthetic aortic
valve, red cell blood transfusion one week
before, and hospitalization for acute pul-
monary infection treated with iv quinolone,
who developed acute left-sided bivalvular IE
C. parapsilosis and S. marcescens septicemia
were considered to be possible secondary
etiological mechanisms of HCAIE.
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parapsilosis, e “exitus” possivelmente por
sepsis a Serratia marcescens. Admitiu-se
HCAIE relacionada com três intervenções
hospitalares, como mecanismos etiológicos
iniciais prováveis: estadia em ambiente
hospitalar superlotado, terapêutica e.v. com
quinolona e transfusão de concentrado
eritrocitário. Posteriormente, a sepsis por
Candida parapsilosis e Serratia marcescens
foram igualmente consideradas como
hipotéticos mecanismos etiológicos
secundários de HCAIE.  
Palavras Chave:
MRSA; endocardite infecciosa valvular esquerda;
endocardite infecciosa em válvula protésica;
vancomicina; linezolido; glomerulonefrite por
imunocomplexos, Candida parapsilosis, 
Serratia marcescens
emia; hypoalbuminemia (2.56 g/dl); and nor-
mal urea and creatinine, with calculated GFR
of 62.3 ml/min. Urinary sediment showed 75
WBCs/μl, but urine culture was negative, as
was urinary antigen for Pneumococcus and
Legionella pneumophila. The chest X-ray
showed cardiomegaly and bilateral peribron-
chitis.
After the first day on iv therapy with lev-
ofloxacin, the patient was afebrile and improv-
ing rapidly, and her WBCs were normal on the
6th day of therapy (Table I). During the night of
the 8th to 9th day of hospitalization she devel-
oped high fever (39 ºC), chills, vomiting,
abdominal pain and headache, and a de novo
mitral systolic murmur (III/VI) was audible.
Conjunctival petechiae and finger splinter
hemorrhages were detected, but retinoscopy
was normal. No hepatomegaly or splenomegaly
were observed. Blood tests on the following
morning showed recurrent and higher leukocy-
tosis (Table I), and urinary sediment revealed
many erythrocytes but no proteinuria. Blood
cultures were taken and MRSA was subse-
quently isolated, susceptible to gentamicin,
vancomycin, teicoplanin and linezolid.
Transesophageal echocardiography performed
on the same day revealed a small vegetation on
the fibrocalcified native mitral valve, but
apparently not on the biological prosthetic aor-
tic valve. One day later right hemiparesis
occurred due to left frontal-parietal ischemic
stroke. Cardiologists did not advise surgery
then or later on due to comorbidities and com-
plications in an 83-year-old patient.
Therapy with vancomycin, gentamicin and
rifampicin was initiated on the day of diagno-
sis of endocarditis, subsequently changed to
linezolid when renal failure ensued, revealed
by blood tests on the 14th day of hospitaliza-
tion (plasma urea 147 mg/dl and creatinine
1.9 mg/dl) (Table I), which was at first pre-
sumed to be due to drug iatrogeny. However,
diuresis becomes progressively lower and on
December 22 2009 (the 22nd day of hospital-
ization) the patient was in anuria with acute
elevation of renal function markers (Table I)
and heart failure (NYHA class III). C3 was
lower than normal, which persisted throughout 613
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on the 8th day of hospitalization due to MRSA
infection with several serious complications:
heart failure, embolic stroke, anuric acute
renal failure due to post-infectious acute
immune complex glomerulonephritis,
fungemia due to Candida parapsilosis, and
septic shock due to Serratia marcescens bac-
teremia following insertion of a permanent
tunneled hemodialysis catheter through the
lumen of a previous temporary hemodialysis
catheter. We considered our patient to be a
case of HCAIE, possible mechanisms of
occurrence of which are reviewed in the
Discussion.
CASE REPORT
An 83-year-old woman was admitted to our
infirmary on November 12 2009 due to acute
hypoxemic respiratory infection (PaO2 35.2
mmHg) of one week’s duration, ten days after
a red cell transfusion in the emergency ward
for iron deficiency anemia of undiagnosed eti-
ology (Hb 8.1 g/dl), presumably related to
warfarin therapy. The patient complained of
fever, cough productive of purulent sputum,
left thoracic pain and progressive dyspnea.
Her past medical history included a biolog-
ical aortic valve prosthesis due to fibrocalcify-
ing disease (November 2004), ischemic/hyper-
tensive cardiomyopathy, chronic atrial fibrilla-
tion, secondary pulmonary hypertension,
ischemic stroke without sequelae, acute bron-
chopneumonia and iron deficiency anemia due
to hemorrhagic gastritis (May 2009). Her father
had died from acute rickettsiosis and her moth-
er from ischemic stroke.
On observation, her temperature was 38.5
ºC, blood pressure 124/68 mmHg, heart rate
~120 bpm, and respiratory rate 26/min. An
aortic systolic ejection murmur (III/VI) was
audible, with no other abnormal sounds. There
were bilateral diffuse rhonchi on lung auscul-
tation. Abdominal semiology was normal and
there was no leg edema.
Laboratory blood tests (Table I) revealed
anemia of chronic disease; leukocytosis with
neutrophilia; INR 2.3; elevated CRP; hypox-
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Although three transthoracic echocardio-
grams performed during the six weeks of ther-
apy showed no new abnormal echocardio-
graphic signs, transesophageal echocardiogra-
phy performed subsequently showed an
apparently new aortic valve infection with
suspected perivalvular abscess cavity (Figure
4). However, urgent heart surgery was refused
by a cardiovascular surgeon, because: (1) after
serial review of all echocardiograms it was
considered that bivalvular endocarditis had
the clinical course, circulating immune com-
plexes were persistently lower than the cut-off
value, and from then on platelets decreased
progressively (Table I). Meanwhile, renal
biopsy revealed endocapillary proliferative
glomerulonephritis due to immune complex
deposition (Figures 1, 2 and 3). Hemodialysis
via a temporary hemodialysis catheter was ini-
tiated and, although anuria persisted, the
heart failure was compensated. Vancomycin
was administered after each dialysis session
beginning on day 15 of renal failure, and line-
zolid was maintained for six weeks (until
January 4 2010), at which time acute-onset
dyspnea developed. On that day blood 
tests revealed worsening anemia and throm-
bocytopenia; WBCs were unexpectedly nor-
mal, and CRP was much lower than before
(Table I).
Table 1. Evolultion of laboratory results
11.11.09 11.17.09 11.19.09 11.23.09 12.02.09 12.18.09 01.04.10
Hb (g/dl) 9.9 10.6 10.9 10.9 9.6 9.3 6.7
WBCs (x109/l) 16.0 9.8 24.7 12.6 12.9 8.6 5.4
N (%) 87.2 64.6 95.0 85.9 88.2 73.4 60
Platelets (x109/l) 247.0 203.0 229.0 87.0 102.0 45.0 30.0
CRP (mg/dl) 33.1 11.5 2.6
Urea (mg/dl) 49 63 147.0 162.0 71.0 61.0
Creatinine (mg/dl) 0.7 0.8 1.8 4.7 3.8 3.1
LDH (U/l) 911 817 956 793 837
C3 (mg/dl)
(75-140.00) 55.80 49.90 55.90
pH 7.457 7.482 6.942
PaCO2 (mmHg) 37.8 35.9
PaO2 (mmHg) 68.6 82.2
HCO3- (mmol/l) 26.9 25.6 4.6
Lactate (mmol/l) 0.9 12.7
been present from the beginning, and that
after six weeks of antibiotic therapy and with
no clinical or laboratory signs of active infec-
tion, the image of an abscess cavity probably
corresponded to an already epithelialized
sequelar cavity; (2) the serious clinical situa-
tion of the patient would result in postopera-
tive death.
Meanwhile, Candida parapsilosis was iso-
lated from a blood culture taken on December
21 2009 (one positive and two negative blood
samples, susceptible to fluconazole, voricona-
zole, amphotericin B and caspofungin), for
which iv fluconazole was initiated as soon as
the result was known (January 2 2010). Serial
blood cultures were no longer positive for
MRSA after the first week of therapy.
Assuming that renal function would not
recover, the temporary hemodialysis catheter
was replaced in the nephrology unit by a per-
manent tunneled catheter inserted through the
lumen of the previous one. On the same day,
several hours after the procedure, severe clin-
ical worsening occurred: on the following day
the patient presented in septic shock and pro-
found lactic acidosis (pH 6.942; cHCO3- 4.6
mmol/l; anion gap 17.5 mmol/l; cLactate 12.7
mmol/l), and was transferred to the intensive
care unit. Assisted ventilation was required,
and iv vancomycin and piperacillin-tazobac-
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Figure 1. Endocapillary proliferation, with scattered PMNs associated with peripheral endocapillary deposits on the right (arrow) 
(HE, x400).
Figure 2. Prominent mesangial and peripheral deposits of C3 (subendothelial location – arrow) (anti-C3 immunofluorescence, x400).
tam antibiotic therapy were prescribed as well
as circulatory support with vasoactive amines,
but the patient died three days later due to
multiorgan failure. Serratia marcescens (sus-
ceptible to piperacillin-tazobactam) was later
isolated from blood cultures obtained during
this period, and two other blood cultures
dated December 30 2009 and January 5 2010
were positive for C. parapsilosis, although this
result was known only after the patient’s
death. Her family did not authorize necropsy.
DISCUSSION
In developed countries, IE is a rare disease,
with an incidence of 3-10 cases/100,000 popu-
lation per year.  A higher prevalence has been
observed in the elderly(1). While rheumatic
heart disease remains the predominant risk
factor in developing countries, in developed
countries newer predisposing factors have aris-
en, such as valve prostheses, degenerative
valve sclerosis and intravenous drug abuse (4),
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Figure 3. Cellular crescent (arrow) associated with endocapillary proliferation (PAS, x400).
and even esthetic procedures such as body
piercing have been implicated in the develop-
ment of IE in individuals with or without pre-
vious heart disease. The incidence of HCAIE
is increasing, representing up to 30% of total
cases (4), which are mostly related to invasive
maneuvers, such as intravenous catheters,
hyperalimentation lines, pacemakers, and
dialysis access, with a consequent high risk of
bacteremia. Aseptic measures during these
procedures are therefore very important (4).
Changes in the conditions associated with
IE have altered the frequency of the etiologi-
cal microorganisms, with the incidence of
streptococcal IE decreasing and that of
staphylococcal IE increasing(1). In fact,
HCAIE, besides being associated with older
age, diabetes, renal impairment and heart fail-
ure, has also been associated with MRSA and
Enterococcus(1). In a smaller proportion of
cases Candida (4%) and Gram-negative bacil-
li (5%) may be the agents responsible for
HCAIE. Mortality and morbidity remain unac-
ceptably high and recent health care exposure
has been identified as an independent predic-
tor of mortality (1).
Prosthetic valve IE represents 10-30%
cases of IE in most developed countries (5). The
risk of early-onset IE is greater for mechanical
heart valves, but later becomes similar for
mechanical devices and bioprostheses (5).
Staphylococcus aureus and coagulase-negative
Staphylococcus are now the most common
cause of prosthetic valve endocarditis and are
associated with a poor prognosis (5). Prosthetic
valve endocarditis is associated with high
mortality despite diagnostic and therapeutic
improvements. Early prosthetic valve endo-
carditis (first eight weeks after surgery) usual-
ly presents with a more acute clinical picture
than late prosthetic valve endocarditis (more
than one year after surgery) (6), but these con-
siderations can be modified in HCAIE.
Unexplained fever in a patient with a pros-
thetic valve should prompt immediate and
careful evaluation for prosthetic valve endo-
carditis. Frequently, new or changing mur-
murs and congestive heart failure are detect-
ed. Blood cultures (only a small percentage of
patients with no previous antibiotic therapy
will have sterile blood cultures) and echocar-
diograms (preferably transesophageal) are of
crucial importance in diagnosis(4, 5, 7). Serial
echocardiograms throughout the clinical course
are of utmost importance for evaluation of the
severity of IE and for the detection of valve
destruction by abscesses, a not uncommon
occurrence in SA valve infections. Real-time
polymerase chain reaction of bacterial rDNA
from surgically removed heart valves is a
recent diagnostic method that is especially
useful in patients with culture-negative IE.
IE’s clinical course may present with vari-
ous complications, as was well illustrated in
our patient’s case. Heart failure is the most
frequent severe complication of IE (4) and con-
gestive heart failure and neurological events
have the strongest influence on the clinical
course and prognosis of IE(4).  Congestive heart
failure is usually due to infection-induced
valve damage, and aortic valve infection is
more frequently associated with congestive
heart failure than is mitral valve infection.
Cavities visualized on ultrasonography are a
sign of perivalvular abscess formation (7).
Systemic emboli are among the most com-
mon clinical sequelae of IE, occurring in up to
40 per cent of patients, and can often predate
the diagnosis. There is a trend towards a high-
er risk of subsequent systemic embolism in
patients with a vegetation >10 mm.
Neurological manifestations occur in 30-40%
of patients, embolic stroke being the most
common and clinically important (8). They are
more frequent when IE is caused by SA and
are associated with increased mortality.
Other neurological complications include
intracranial hemorrhage resulting either from
hemorrhage into an infarct or from rupture of
a mycotic aneurysm, cerebral abscesses,
purulent meningitis, severe headaches,
seizures and encephalopathy. Rapid treatment
with antibiotics is of major importance, since
the rate of embolic neurological events
decreases significantly after it is begun (8).
Despite antibiotics having been initiated as
soon as a diagnosis of IE was confirmed, our
patient still suffered a neurological event
which affected prognosis as well as clinical
and surgical options.
Renal events in IE include renal infarcts
due to septic embolism occluding interlobular
arteries and arterioles (particularly in SA endo-
carditis), renal cortical necrosis, antibiotic-
induced interstitial nephritis, renal abscesses
and glomerulonephritis that may or may not be
secondary to immunoglobulin and complement
deposition in mesangial and subendothelial
locations (3, 9). Renal biopsy specimens may
reveal focal and segmental or diffuse prolifera-
tive lesions, often associated with infiltrating
cells, typically monocytes/macrophages, and
617
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Figure 4. Transesophageal echocardiogram: biological aortic prosthesis (a) and adjacent epithelialized aortic abscess cavity (b)
sometimes a neutrophilic exudate. Crescents
are often associated with proliferative lesions.
Rarely, rapidly progressive exudative glomeru-
lonephritis develops, leading to end-stage renal
failure unresponsive to antibiotic therapy.
Immunostaining reveals granular C3 deposition,
which is often but not always accompanied by
IgG or IgM (3). Persistent circulating immune
complexes and C3 depletion, despite antibiotic
treatment, have been shown to indicate the fail-
ure of therapy and a high probability of persist-
ent infection and glomerulonephritis (3).
Renal insufficiency as a result of immune
complex-mediated glomerulonephritis occurs
in less than 15% of cases. Patients with IE
due to MRSA are significantly more likely to
have complicating renal insufficiency and to
experience persistent bacteremia than those
with IE due to MSSA. Patients may develop
endocarditis-related glomerulonephritis
despite appropriate antibiotic therapy, and the
development of renal failure may be delayed
until several days after antibiotic therapy is
initiated. Patients presenting with advanced
renal failure usually have a poor outcome (3).
Rarer complications are vertebral osteomye-
litis, acute septic arthritis, and metastatic
abscesses in the spleen and soft tissues.
Additionally, all measures associated with hos-
pital treatment of IE can by themselves cause
their own complications (hospital infections)(9).
Mortality from prosthetic valve IE is
extremely high (20-30% of cases)(6). Our
patient clearly illustrates several risk factors
associated with increased mortality during the
clinical course of IE: congestive heart failure,
renal failure, neurological events, old age and
comorbidities (previous heart disease and pul-
monary hypertension), as well as exposure in
an overcrowded infirmary.
Treatment of prosthetic valve IE relies on a
combination of prolonged antimicrobial therapy
and, in about half of patients, valve surgery
(abscess drainage and/or removal of endovascu-
lar prosthetic material for treatment of uncon-
trolled sepsis)(4, 5). Recommended antimicrobial
therapy for prosthetic valve IE due to MRSA is
an association of vancomycin plus rifampin for
6-8 weeks plus gentamicin for two weeks (or an
alternative drug in gentamicin-resistant SA) (6).
By contrast, vancomycin has worse results in
the treatment of endocarditis due to MSSA than
beta-lactam antibiotics.
When assessing treatment outcomes, it is
important to bear in mind the recent emergence
of multiple MRSA phenotypes with reduced
susceptibility to glycopeptides. Minimum
inhibitory concentrations (MICs) of vancomycin
for MRSA in these cases can be higher than
usual (1-2 μg/ml). These strains are van-
comycin-intermediate SA (VISA) with MICs
between 4-8 μg/ml, heterogeneous VISA
(hVISA), which contains a subpopulation of
cells with reduced susceptibility to vancomycin
(MICs ≥4 μg/ml), and vancomycin-resistant SA
(VRSA) (MICs ≥16 μg/ml).  Also to be consid-
ered is the occurrence of MRSA in a communi-
ty setting with silent acquisition in patients
who were previously in a healthcare environ-
ment, or household contacts, as well as truly
community-acquired MRSA with Panton-
Valentine leukocidin genes(10). At our hospital
we have no facilities to investigate this issue.
Not all novel pharmaceutical molecules
such as lisostaphin, quinupristin-dalfopristin,
linezolid, daptomycin and tigecycline are valid
proven options for left-sided acute MRSA
endocarditis, although they exhibit comparable
in vitro activity against MRSA. The oxazolidi-
none linezolid appeared to be effective in sev-
eral recent studies (10).
Since a considerable proportion of prosthet-
ic valve IE patients may require surgery, careful
planning and individualization of intervention
timing is essential. The optimal time to perform
surgery is before severe hemodynamic disabili-
ty or spread of the infection to perivalvular tis-
sue have occurred. The most frequent indica-
tions for surgery are heart failure, uncontrolled
infection and prevention of embolic events(9).
The risks associated with surgery are higher for
patients with prosthetic valve endocarditis than
for those with native valve IE, but the recom-
mendations for surgery are essentially the same
for both forms of endocarditis.
It has long been known that if not con-
traindicated for any reason, combined medical
and surgical treatment significantly improves618
Rev Port Cardiol 
Vol. 30 Junho 11 / June 11
outcome, with mortality rates of SA prosthetic
valve endocarditis diminishing from 70% to
25% of cases (8). Some authors consider that
SA prosthetic valve IE alone may be an indica-
tion for valve replacement surgery. However, as
Paterick et al. (9) clearly advise, surgery is not
indicated if complications or comorbid condi-
tions suggest that the possibility of recovery is
remote.
Unfortunately, in the case of our patient we
were initially only able to diagnose native
mitral valve endocarditis, and the patient also
presented complications that despite being to
some extent reasons to perform surgery, were
also a contraindication, due to their severity.
The neurological event that our patient suf-
fered affected the planning of surgical treat-
ment. When central nervous system complica-
tions occur, timing for surgical treatment can-
not be precisely defined. It should usually be
performed after two or four weeks, respective-
ly,  if an embolic or hemorrhagic event has
occurred, and ideally in the absence of heart
failure (8). Anuria due to immune complex
acute glomerulonephritis also made immedi-
ate surgery impossible.
During the clinical evolution our patient
presented with two hospital infections: (1)
positive blood culture for Candida parapsilo-
sis on the 39th day of hospitalization after a
prolonged course of several parenteric antibi-
otics, but not known until the 56th day, at
which time iv fluconazole was initiated; (2)
septic shock due to septicemia from Serratia
marcescens infection, probably occurring after
the insertion of a tunnelized hemodialysis
catheter through a previous one. S. marcescens
was isolated in blood cultures taken two days
before the patient died. S. marcescens, a Gram-
negative Enterobacteriacea, is an opportunistic
pathogen in humans, responsible for hospital
outbreaks, particularly in the ICU. Serratia is
responsible for about 2% of nosocomial bac-
teremias and infections of the lower respiratory
tract, urinary tract, surgical wounds, and skin
and soft tissues. S. marcescens infections
should be treated with an aminoglycoside plus
an anti-Pseudomonas beta-lactam.
In conclusion, we considered several pos-
sible mechanisms of MRSA HCAIE occur-
rence in our patient: (1) acute IE due to MRSA
is usually HCAIE acquired inside hospitals
and nursing and residential homes, where
there is frequent use of antibiotics such as
macrolides, cephalosporins, quinolones, and
to some extent aminoglycosides (10); (2) intra-
venous procedures utilized several times in
the environment of our hospital (emergency
ward and infirmary); (3) in general, inade-
quate ward or unit staff, or staff training, over-
crowding of patients, lack of isolation facili-
ties, frequent relocation of patients and staff,
and poor attention to infection control proce-
dures increase the risk of nosocomial infec-
tions. It is also suggested that some MRSA
infections presenting from the community are
sometimes associated with silent acquisition
after patients have been in an inpatient envi-
ronment for more than five days within the
past year (10); (4) although very rare, there is a
risk of SA infection and even of death after red
blood cell transfusion (as reported by the FDA
and other sources) (11).
The antibiotic association utilized at the
beginning was decided based on the possibility
of prosthetic valve HCAIE. Unfortunately the
first diagnosis was an isolated infection of a
native valve, with several acute and serious
complications occurring sequentially, that
made it impossible to proceed with  prosthetic
valve surgery. This case is presented to illus-
trate how the evolution of a case of acute IE due
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